TEF-1 Polyclonal Antibody

    • Catalog No.:YT4596
    • Applications:WB;IHC;IF;ELISA
    • Reactivity:Human;Mouse;Rat
      • Target:
      • TEF-1
      • Fields:
      • >>Hippo signaling pathway;>>Hippo signaling pathway - multiple species
      • Gene Name:
      • TEAD1
      • Protein Name:
      • Transcriptional enhancer factor TEF-1
      • Human Gene Id:
      • 7003
      • Human Swiss Prot No:
      • P28347
      • Mouse Swiss Prot No:
      • P30051
      • Immunogen:
      • Synthesized peptide derived from TEF-1 . at AA range: 30-110
      • Specificity:
      • TEF-1 Polyclonal Antibody detects endogenous levels of TEF-1 protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:40000.. IF 1:50-200
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • TEAD1;TCF13;TEF1;Transcriptional enhancer factor TEF-1;NTEF-1;Protein GT-IIC;TEA domain family member 1;TEAD-1;Transcription factor 13;TCF-13
      • Observed Band(KD):
      • 50kD
      • Background:
      • This gene encodes a ubiquitous transcriptional enhancer factor that is a member of the TEA/ATTS domain family. This protein directs the transactivation of a wide variety of genes and, in placental cells, also acts as a transcriptional repressor. Mutations in this gene cause Sveinsson's chorioretinal atrophy. Additional transcript variants have been described but their full-length natures have not been experimentally verified. [provided by RefSeq, May 2010],
      • Function:
      • disease:Defects in TEAD1 are the cause of Sveinsson chorioretinal atrophy (SCRA) [MIM:108985]; also known as atrophia areata (AA) or helicoidal peripapillary chorioretinal degeneration (HPCD). SCRA is characterized by symmetrical lesions radiating from the optic disk involving the retina and the choroid.,function:Binds specifically and cooperatively to the SPH and GT-IIC "enhansons" (5'-GTGGAATGT-3') and activates transcription in vivo in a cell-specific manner. The activation function appears to be mediated by a limiting cell-specific transcriptional intermediary factor (TIF). Involved in cardiac development. Binds to the M-CAT motif.,similarity:Contains 1 TEA DNA-binding domain.,tissue specificity:Preferentially expressed in skeletal muscle. Lower levels in pancreas, placenta, and heart.,
      • Subcellular Location:
      • Nucleus.
      • Expression:
      • Preferentially expressed in skeletal muscle. Lower levels in pancreas, placenta, and heart.
      • Products Images
      • Immunohistochemical analysis of paraffin-embedded human Small intestinal stromal tumor. 1, Tris-EDTA,pH9.0 was used for antigen retrieval. 2 Antibody was diluted at 1:200(4° overnight.3,Secondary antibody was diluted at 1:200(room temperature, 45min).